filmov
tv
Could cancer vaccine mark a turning point in preventing relapse? • FRANCE 24 English
Показать описание
A vaccine being developed by French company Transgene that is tailored to each individual patient using artificial intelligence could help prevent relapses, says the company. The 4050 vaccine has already been successfully tested on a sample of 16 patients with head and neck cancers and could theoretically be used to treat a variety of different cancers.
#cancer #vaccine #relapse
#cancer #vaccine #relapse
0:01:39
Could cancer vaccine mark a turning point in preventing relapse? • FRANCE 24 English
0:04:44
Cancer vaccine will open up ‘new field’ of therapies: Mark Hyman | CUOMO
0:01:04
Groundbreaking mRNA vaccine could help cure pancreatic cancer | New York Post
0:02:12
New study on the effectiveness of pancreatic cancer vaccine
0:52:34
Yale Canine Cancer Vaccine - Prof. Mark Mamula
0:00:47
VERIFY: COVID-19 vaccine could give false positive for breast cancer
0:02:24
Personalized cancer vaccine helps patient
0:02:14
Defying cancer: New vaccine shows promise
0:01:53
Thousands lining up for compensation, claiming the COVID vaccine made them sick | 7NEWS
0:04:01
Man with vaccine side-effect has message for unvaccinated
0:08:06
How To Talk With Parents And Caregivers About The HPV Vaccine
0:01:00
Prof Mamula - Canine Cancer Immunotherapy EGFR/HER2 Vaccine #Shorts
0:18:04
Peptide vaccine clinical trial - Discussion with Dr. Mark Yarchoan
0:02:25
Yale researchers see promising results in Cancer vaccine
0:02:03
When Will We Have A Cancer Vaccine | UW Medicine Advancement
0:03:24
'Tumors just vanished': Cancer patients now in remission after drug trial
0:01:01
Pfizer Founders Working on Cancer Vaccine | News You Can Use | October 21
0:12:21
Kim Iversen: Does mRNA Change Your DNA? Breaking Down AP and Reuters Fact Check
0:06:57
A Vaccine Against ... Cancer?
0:05:25
A vaccine for pancreatic cancer is showing promise. Here's how it works.
0:00:44
How Moderna and Merck's mRNA Cancer Vaccine Could Save Lives from Melanoma
0:13:33
Coronavirus vaccine Q&A with Professor Mark Saunders
0:01:51
Wyss Institute Implantable Cancer Vaccine
0:24:43
EGFR / HER2 Vaccine Q&A | March 2023
Комментарии